```mermaid
flowchart TD
S100B["S100B<br/>Calcium-binding protein"]
S100B -->|"activates"| Neuroinflammation["Neuroinflammation<br/>Glial activation"]
S100B -->|"biomarker_for"| TBI["Traumatic Brain Injury<br/>Acute neural damage"]
S100B -->|"activates"| ALS["ALS<br/>Motor neuron disease"]
S100B -->|"activates"| MS["Multiple Sclerosis<br/>Demyelinating disease"]
S100B -->|"activates"| C1Q["C1Q<br/>Complement activation"]
S100B -->|"activates"| HMGB1["HMGB1<br/>Damage-associated<br/>molecular pattern"]
S100B -->|"activates"| TGM2["TGM2<br/>Transglutaminase 2"]
Neuroinflammation -->|"leads_to"| Microglial_activation["Microglial Activation<br/>Pro-inflammatory state"]
C1Q -->|"triggers"| Complement_cascade["Complement Cascade<br/>Synaptic pruning"]
HMGB1 -->|"promotes"| Cytokine_release["Cytokine Release<br/>IL-1beta, TNF-alpha"]
S100B -->|"biomarker_for"| BDNF["BDNF<br/>Neuroprotective factor"]
S100B -->|"associated_with"| Aging["Aging<br/>Cellular senescence"]
Microglial_activation -->|"causes"| Synaptic_loss["Synaptic Loss<br/>Neuronal dysfunction"]
Complement_cascade -->|"results_in"| Synaptic_loss
Cytokine_release -->|"contributes_to"| Neurodegeneration["Neurodegeneration<br/>Progressive cell death"]
Aging -->|"accelerates"| Neuroinflammation
Synaptic_loss -->|"leads_to"| Neurodegeneration
style S100B fill:#006494
style BDNF fill:#1b5e20
style Neuroinflammation fill:#ef5350
style TBI fill:#e
S100B Gene plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
S100B is a gene encoding a calcium-binding protein of the S100 family, playing crucial roles in neuronal function, astrocyte biology, and neuroinflammation. Originally discovered as a brain-specific protein, S100B has emerged as a critical player in neurodegenerative diseases including Alzheimer's disease (AD), Parkinson's disease (PD), and amyotrophic lateral sclerosis (ALS). This page provides comprehensive information about S100B's structure, function, signaling pathways, and therapeutic implications in neurodegeneration.
<div class="infobox infobox-gene">
<table>
<tr><th colspan="2" style="background:#e8f4f8; text-align:center; font-size:1.1em;">S100 Calcium Binding Protein B</th></tr>
<tr><td><strong>Gene Symbol</strong></td><td>S100B</td></tr>
<tr><td><strong>Full Name</strong></td><td>S100 Calcium Binding Protein B</td></tr>
<tr><td><strong>Chromosome</strong></td><td>21q22.3</td></tr>
<tr><td><strong>NCBI Gene ID</strong></td><td>[6275](https://www.ncbi.nlm.nih.gov/gene/6275)</td></tr>
<tr><td><strong>OMIM</strong></td><td>176990</td></tr>
<tr><td><strong>Ensembl ID</strong></td><td>ENSG00000122574</td></tr>
<tr><td><strong>UniProt ID</strong></td><td>[P16401](https://www.uniprot.org/uniprot/P16401)</td></tr>
<tr><td><strong>Protein Length</strong></td><td>92 amino acids</td></tr>
<tr><td><strong>Protein Family</strong></td><td>S100 EF-hand calcium binding proteins</td></tr>
<tr><td><strong>Associated Diseases</strong></td><td>Alzheimer's Disease, Parkinson's Disease, ALS, Brain Injury, Down Syndrome</td></tr>
</table>
</div>
The S100B gene is located on chromosome 21q22.3 and consists of three exons spanning approximately 4.5 kb of genomic DNA. The gene encodes a 92-amino acid protein with a molecular weight of approximately 10.5 kDa. S100B belongs to the S100 family of EF-hand calcium-binding proteins, which evolved through gene duplication events dating back over 500 million years [@marenholz2004].
The S100 family comprises over 20 members in humans, characterized by:
S100B adopts a characteristic S100 protein fold consisting of:
S100B functions primarily as a homodimer (S100B2), though higher-order oligomers (tetramers, hexamers) have been reported. Dimerization is essential for:
At nanomolar concentrations, S100B exhibits potent neurotrophic effects:
S100B participates in intracellular calcium signaling by:
As the most abundant astrocyte-specific protein, S100B serves multiple functions:
S100B can be secreted via a non-classical pathway and acts extracellularly:
S100B binding to RAGE activates multiple signaling cascades:
S100B → RAGE → NF-κB → Pro-inflammatory gene expression
↓
→ MAPKs (ERK1/2, p38, JNK) → Cell proliferation/differentiation
↓
→ PI3K/AKT → Pro-survival signaling
↓
→ NADPH oxidase → ROS production
S100B interacts with p53 tumor suppressor protein:
S100B activates NF-κB through multiple mechanisms:
S100B is heavily implicated in Alzheimer's disease pathogenesis:
| Finding | Significance |
|---------|--------------|
| Elevated in AD brain | 10-50-fold increase in [hippocampus](/brain-regions/hippocampus) and [cortex](/brain-regions/cortex) |
| Colocalizes with amyloid plaques | S100B+ [astrocytes](/entities/astrocytes) surround plaques |
| Elevated in CSF | Biomarker potential |
| Associated with [tau](/proteins/tau) pathology | Correlates with neurofibrillary tangles |
S100B alterations in PD include:
In ALS:
S100B serves as a clinical biomarker:
Given the chromosome 21 location:
S100B has been investigated as a biomarker for:
Strategies targeting S100B include:
[@marenholz2004]: Marenholz I, Heizmann CW, Fritz G. S100 proteins in mouse and man: from evolution to function and pathology (including an update of the nomenclature). Biochem Biophys Res Commun. 2004;322(4):1111-1122. PMID: 15336978(https://pubmed.ncbi.nlm.nih.gov/15336978/)
[@donato2009]: Donato R, Sorci G, Riuzzi F, et al. S100B's double life: intracellular regulator and extracellular signal. Biochim Biophys Acta. 2009;1793(6):1008-1022. PMID: 19110091(https://pubmed.ncbi.nlm.nih.gov/19110091/)
[@leclerc2009]: Leclerc E, Fritz G, Vetter SW, Heizmann CW. Binding of S100 proteins to RAGE: an update. Biochim Biophys Acta. 2009;1793(6):993-1007. PMID: 19110054(https://pubmed.ncbi.nlm.nih.gov/19110054/)
[@rothermundt2003]: Rothermundt M, Peters M, Prehn JH, Arolt V. S100B in brain damage and neurodegeneration. Microsc Res Tech. 2003;60(6):614-632. PMID: 12645008(https://pubmed.ncbi.nlm.nih.gov/12645008/)
[@van2003]: Van Eldik LJ, Wainwright MS. The Janus face of glial-derived S100B: beneficial and detrimental functions in the brain. Restor Neurol Neurosci. 2003;21(3-4):97-108. PMID: 14530572(https://pubmed.ncbi.nlm.nih.gov/14530572/)
[@peskind2001]: Peskind ER, Griffin WS, Akama KT, et al. Cerebrospinal fluid S100B is elevated in the earlier stages of Alzheimer's disease. Neurochem Int. 2001;39(5-6):409-413. PMID: 11578776(https://pubmed.ncbi.nlm.nih.gov/11578776/)
[@liu2022]: Liu J, Li S, Chen W, et al. S100B as an indicator of astrocyte activation and tau pathology in Alzheimer's disease. J Alzheimers Dis. 2022;85(4):1601-1613. PMID: 34882546(https://pubmed.ncbi.nlm.nih.gov/34882546/)
S100B Gene plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
The study of S100B Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
The following diagram shows the key molecular relationships involving S100B Gene discovered through SciDEX knowledge graph analysis: